Stock Track | Roivant Sciences Soars 5.27% After-Hours as Analysts Upgrade Financial Forecasts

Stock Track02-12

Roivant Sciences Ltd. (NASDAQ:ROIV) stock surged 5.27% in after-hours trading on Wednesday, following analysts' significant upgrades to their revenue and earnings estimates for the company.

Analysts covering Roivant Sciences revised their consensus estimates, projecting $43 million in revenue for the company in 2026, a sharp increase from their previous forecast of $36 million. Additionally, they reduced their loss estimates for the next year, now expecting losses of $1.17 per share instead of the earlier projection of $1.19 per share.

The upgraded forecasts reflect analysts' optimism about Roivant Sciences' sales pipeline and potential trajectory towards profitability. Despite the revisions, analysts maintained their price target of $16.00 for the stock, implying their long-term valuation remains unchanged.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1114746336?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-02-13 06:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114746336","market":"hk","top_or_hot":-1,"title":"Stock Track | Roivant Sciences Soars 5.27% After-Hours as Analysts Upgrade Financial Forecasts","media":"Stock Track","content":"<p>Roivant Sciences Ltd. (NASDAQ:ROIV) stock surged 5.27% in after-hours trading on Wednesday, following analysts' significant upgrades to their revenue and earnings estimates for the company.</p>\n\n<p>Analysts covering Roivant Sciences revised their consensus estimates, projecting $43 million in revenue for the company in 2026, a sharp increase from their previous forecast of $36 million. Additionally, they reduced their loss estimates for the next year, now expecting losses of $1.17 per share instead of the earlier projection of $1.19 per share.</p>\n\n<p>The upgraded forecasts reflect analysts' optimism about Roivant Sciences' sales pipeline and potential trajectory towards profitability. Despite the revisions, analysts maintained their price target of $16.00 for the stock, implying their long-term valuation remains unchanged.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Roivant Sciences Soars 5.27% After-Hours as Analysts Upgrade Financial Forecasts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Roivant Sciences Soars 5.27% After-Hours as Analysts Upgrade Financial Forecasts\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-13 06:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Roivant Sciences Ltd. (NASDAQ:ROIV) stock surged 5.27% in after-hours trading on Wednesday, following analysts' significant upgrades to their revenue and earnings estimates for the company.</p>\n\n<p>Analysts covering Roivant Sciences revised their consensus estimates, projecting $43 million in revenue for the company in 2026, a sharp increase from their previous forecast of $36 million. Additionally, they reduced their loss estimates for the next year, now expecting losses of $1.17 per share instead of the earlier projection of $1.19 per share.</p>\n\n<p>The upgraded forecasts reflect analysts' optimism about Roivant Sciences' sales pipeline and potential trajectory towards profitability. Despite the revisions, analysts maintained their price target of $16.00 for the stock, implying their long-term valuation remains unchanged.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"","article_id":"1114746336","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114746336","pubTimestamp":1739398594,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Roivant Sciences Ltd.  stock surged 5.27% in after-hours trading on Wednesday, following analysts' significant upgrades to their revenue and earnings estimates for the company.Analysts covering Roivant Sciences revised their consensus estimates, projecting $43 million in revenue for the company in 2026, a sharp increase from their previous forecast of $36 million. Additionally, they reduced their loss estimates for the next year, now expecting losses of $1.17 per share instead of the earlier pro","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"分析师上调财务预测，Roivant Sciences盘后股价飙升5.27%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ROIV":1},"content_text":"Roivant Sciences Ltd. (NASDAQ:ROIV) stock surged 5.27% in after-hours trading on Wednesday, following analysts' significant upgrades to their revenue and earnings estimates for the company.\nAnalysts covering Roivant Sciences revised their consensus estimates, projecting $43 million in revenue for the company in 2026, a sharp increase from their previous forecast of $36 million. Additionally, they reduced their loss estimates for the next year, now expecting losses of $1.17 per share instead of the earlier projection of $1.19 per share.\nThe upgraded forecasts reflect analysts' optimism about Roivant Sciences' sales pipeline and potential trajectory towards profitability. Despite the revisions, analysts maintained their price target of $16.00 for the stock, implying their long-term valuation remains unchanged.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.4","shortVersion":"4.32.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1114746336"}